Fig. 6

NXT ameliorated cardiovascular abnormalities in heg1^△25 mutant. A Representative images of Tg(cmlc2:eGFP), Tg(heg1^△25; cmlc2:eGFP) treated with or without NXT (ventral view). (V ventricle; A atria). B Representative images of Tg(fik1:eGFPi), Tg(heg1^△25; fik1:eGFP) treated with or without NXT (lateral view). (DA dorsal aorta; PCV posterior main vein). C The expressions of cardiovascular markers, as determined by qRT-PCR, were significantly rescued by NXT treatment in heg1^△25 mutant. Data are represented as mean  ± SD. ^#p  <  0.05, ^##p  <  0.01, ^###p  <  0.001 vs control group; *p  <  0.05, ***p  <  0.001 vs heg1^△25 mutant group